Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Leukemia Myeloid Aggressive-Phase

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Leukemia Myeloid Aggressive-Phase:

Pubmed Logo
Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia.
BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by an...		13th June, 2006
Groupe Instabilite Genetique et Cancer, Institut de Pharmacologie et de Anticancer Res. 2006 Jan-Feb;26(1B):523-5.
Gingival involvement in a patient with CD56+ chronic myelomonocytic leukemia.
Leukemic infiltration of the gingiva is most commonly reported to be...		29th July, 2004
Dokuz Eylul University School of Medicine, Division of Leuk Lymphoma. 2004 Feb;45(2):415-8.

Press Releases About Leukemia Myeloid Aggressive-Phase:

 BioPortfolio Logo
Pharmasset Reports Fiscal Year End 2009 Financial Results 25th November, 2009 Pharmasset, Inc.
PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to
Onyx Pharmaceuticals Announces December 2009 Investor Events 25th November, 2009 Onyx Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company will host two investor events in December: ASH Briefing December 7,
The Lupus Foundation of America Hosts Special Webinar to Discuss BENLYSTA(TM) Results 25th November, 2009 Lupus Foundation of America
WHAT: The Lupus Foundation of America (LFA) invites those living with lupus to a special Webinar with LFA's Medical Director, Dr. Joan Merrill. Human Genome Sciences (HGSI) and GlaxoSmithKline
Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 25th November, 2009 Ardea Biosciences, Inc.
SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, Pharm.D., president and chief executive officer, will present at the Piper
Reportlinker Adds Wound Care Products - A World Market Analysis 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Wound Care Products - A World Market Analysis http://www.reportlinker.com

BioPortfolio Ltd. offers e-mail and postal lists for Leukemia Myeloid Aggressive-Phase scientists - we have details of around 2 individuals working on Leukemia Myeloid Aggressive-Phase .


This page has been viewed 259 times
Recent Search Terms used to find this page: aggressive luekemia | aggresive leuk | aggressive myeloid | Agressive leukemia | aggressive leukemia | aggressive leukemia | aggressive myeloid leukemia | myeloid luekemia | aggressive leukemia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Leukemia Myeloid Aggressive-Phase across BioPortfolio, or for Leukemia Myeloid Aggressive-Phase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.